Migenix Inc.
Records under this name other than patents Migenix Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,138,144 | Antimicrobial cationic peptides and formulations thereof Formerly held Term ended Term ended Oct 9, 2023 · From the USPTO record | Term ended | Term ended Oct 9, 2023 | From the USPTO record |
| US 8,933,029 | Antimicrobial and anti-inflammatory peptides Formerly held Lapsed on the fee record Ended Jan 13, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 13, 2023 | From the USPTO record |
| US 6,835,536 | Antimicrobial cationic peptides and formulations thereof Formerly held Term ended Term ended Nov 19, 2022 · From the USPTO record | Term ended | Term ended Nov 19, 2022 | From the USPTO record |
| US 6,881,831 | Nucleic acid-based compounds and methods of use thereof Term ended Term ended May 15, 2022 · From the USPTO record | Term ended | Term ended May 15, 2022 | From the USPTO record |
| US 7,256,179 | Nucleic acid-based compounds and methods of use thereof Term ended Term ended May 15, 2022 · From the USPTO record | Term ended | Term ended May 15, 2022 | From the USPTO record |
| US 7,709,449 | Nucleic acid-based compounds and methods of use thereof Lapsed on the fee record Ended May 4, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2022 | From the USPTO record |
| US 6,620,796 | Combinatorial library synthesis and pharmaceutically active compounds produced thereby Term ended Term ended Nov 8, 2020 · From the USPTO record | Term ended | Term ended Nov 8, 2020 | From the USPTO record |
| US 7,655,623 | Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same Formerly held Lapsed on the fee record Ended Feb 2, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 2, 2018 | From the USPTO record |
| US 6,180,604 | Compositions and methods for treating infections using analogues of indolicidin Formerly held Term ended Term ended Aug 20, 2017 · From the USPTO record | Term ended | Term ended Aug 20, 2017 | From the USPTO record |
| US 6,503,881 | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics Formerly held Term ended Ended no later than Aug 20, 2017 · From the USPTO record | Term ended | Ended no later than Aug 20, 2017 | From the USPTO record |